250 related articles for article (PubMed ID: 27366943)
1. A pan-cancer analysis of MYC-PVT1 reveals CNV-unmediated deregulation and poor prognosis in renal carcinoma.
Posa I; Carvalho S; Tavares J; Grosso AR
Oncotarget; 2016 Jul; 7(30):47033-47041. PubMed ID: 27366943
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma.
Bao X; Duan J; Yan Y; Ma X; Zhang Y; Wang H; Ni D; Wu S; Peng C; Fan Y; Gao Y; Li X; Chen J; Du Q; Zhang F; Zhang X
Cancer Biomark; 2017 Dec; 21(1):55-63. PubMed ID: 29081406
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J
Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis.
Jin K; Wang S; Zhang Y; Xia M; Mo Y; Li X; Li G; Zeng Z; Xiong W; He Y
Cell Mol Life Sci; 2019 Nov; 76(21):4275-4289. PubMed ID: 31309249
[TBL] [Abstract][Full Text] [Related]
5. C-Myc-activated long non-coding RNA PVT1 enhances the proliferation of cervical cancer cells by sponging miR-486-3p.
Wang C; Zou H; Chen A; Yang H; Yu X; Yu X; Wang Y
J Biochem; 2020 Jun; 167(6):565-575. PubMed ID: 31943014
[TBL] [Abstract][Full Text] [Related]
6. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
[TBL] [Abstract][Full Text] [Related]
7. High amplification of PVT1 and MYC predict favorable prognosis in early ovarian carcinoma.
Yamamoto A; Kurata M; Yamamoto K; Nogawa D; Inoue M; Ishibashi S; Ikeda M; Miyasaka N; Kitagawa M
Pathol Res Pract; 2020 Nov; 216(11):153175. PubMed ID: 32841774
[TBL] [Abstract][Full Text] [Related]
8. LINC00997, a novel long noncoding RNA, contributes to metastasis via regulation of S100A11 in kidney renal clear cell carcinoma.
Chang Y; Li N; Yuan W; Wang G; Wen J
Int J Biochem Cell Biol; 2019 Nov; 116():105590. PubMed ID: 31442606
[TBL] [Abstract][Full Text] [Related]
9. The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer.
Shigeyasu K; Toden S; Ozawa T; Matsuyama T; Nagasaka T; Ishikawa T; Sahoo D; Ghosh P; Uetake H; Fujiwara T; Goel A
Mol Cancer; 2020 Nov; 19(1):155. PubMed ID: 33148262
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA PVT1 acts as an oncogenic driver in human pan-cancer.
You Z; Xu S; Pang D
J Cell Physiol; 2020 Nov; 235(11):7923-7932. PubMed ID: 31957871
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.
Kong R; Zhang EB; Yin DD; You LH; Xu TP; Chen WM; Xia R; Wan L; Sun M; Wang ZX; De W; Zhang ZH
Mol Cancer; 2015 Apr; 14():82. PubMed ID: 25890171
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
[TBL] [Abstract][Full Text] [Related]
13. Amplification and the clinical significance of circulating cell-free DNA of PVT1 in breast cancer.
Li X; Chen W; Wang H; Wei Q; Ding X; Li W
Oncol Rep; 2017 Jul; 38(1):465-471. PubMed ID: 28534994
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
[TBL] [Abstract][Full Text] [Related]
15. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis.
Hu F; Zeng W; Liu X
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630
[TBL] [Abstract][Full Text] [Related]
16. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract][Full Text] [Related]
17. High Expression of long non-coding RNA PVT1 predicts metastasis in Han and Uygur Patients with Gastric Cancer in Xinjiang, China.
Ren X; Cao D; Yang L; Li X; Zhang W; Xiao Y; Xi Y; Li F; Li D; Pan Z
Sci Rep; 2019 Jan; 9(1):548. PubMed ID: 30679629
[TBL] [Abstract][Full Text] [Related]
18. Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma.
Khadirnaikar S; Kumar P; Pandi SN; Malik R; Dhanasekaran SM; Shukla SK
Mol Carcinog; 2019 Apr; 58(4):544-553. PubMed ID: 30520148
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of LncRNA PVT1 and Its Potential Target Gene Network in Human Cancers: a Comprehensive Inquiry Based Upon 21 Cancer Types and 9972 Cases.
He RQ; Qin MJ; Lin P; Luo YH; Ma J; Yang H; Hu XH; Chen G
Cell Physiol Biochem; 2018; 46(2):591-608. PubMed ID: 29617692
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma.
Jiang H; Chen H; Wan P; Song S; Chen N
Aging (Albany NY); 2020 Nov; 12(24):25865-25877. PubMed ID: 33234727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
